Global Biologic Imaging Reagents Market by Type (MRI Reagents, Ultrasound Reagents, X-ray and CT Reagents), By Application (Hospital Use, Clinic Use) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
The Global Biologic Imaging Reagents Market size is expected to grow from USD 2.6 billion in 2021 to reach USD 3.8 billion by 2028, at a CAGR of 7.2% during the forecast period (2021-2028). The growth of the market can be attributed to increasing demand for advanced diagnostic tests and growing use of electronic health records across hospitals and clinics globally, which are driving the adoption of imaging technologies among physicians as well as patients, thereby leading to an increased need for reagents used in these tests.
Biologic Imaging Reagents can be defined as a type of substance and chemicals that are used in the process of medical imaging. Biologic Imaging Reagents work by increasing the contrast or visibility within an image. These reagents can be exposed to either visible, ultraviolet (UV), or infrared light which will then react with a chemical called fluorophore from another substance on an object to make it more visible within an image. By design, Biologic Imaging Reagents do not have any adverse effects on humans and animals.
On the basis of Type, the market is segmented into MRI Reagents, Ultrasound Reagents, CT/ X-ray, and others.
MRI Reagents:
MRI Reagents are also known as magnetic resonance imaging reagents, which are the substances that are used in order to process images of the human body. These include contrast agents and dyes. They may be injected into a patient before or during MRI scans for various purposes such as improved visualization of internal organs and tissues or diagnosis by producing contrasting areas on an image map.
MRI Reagents are mainly used in MRI machines. In MRIs, the magnetic field and radio waves emitted from a scanner produce an electric current that moves through the body of the person being studied to create detailed images of internal structures. In this process, a biologic imaging reagent is needed for enhancement or visualization purposes.
Ultrasound Reagents:
Ultrasound reagents are the specific chemicals used for diagnostic ultrasound imaging. Ultrasounds create images of various organs and tissues in a patient's body using sound waves and by mapping these reflections to produce digital pictures or video clips on computer screens. They can be used for diagnosis, screening procedures, medical research, treatment planning, guidance during minimally invasive surgery (such as keyhole surgeries), image-guided therapy & radiation therapy.
Ultrasounds emit high-frequency sounds (above 20 kHz) into the human body, and images can be generated using either real-time scanning techniques or recorded scans.
CT/ X-ray:
An X-ray is a form of electromagnetic radiation which, when passing through an object, allows the shape of that object to be determined. A CT scan or Computed Tomography Scan uses data from multiple x-rays taken in rapid succession with computer processing for more accurate imaging at different angles around the body. They are used to diagnose and treat many diseases such as cancer and heart disease.
CT scans are typically used for the diagnosis of diseases and injuries within the body. They can be used to detect cancer, heart disease, or injury. X-ray machines have also been adapted for other uses such as in-car inspections. CT/ X-rays are sometimes used before surgery to plan out the most effective course of procedure that will not damage any vital organs during treatment. They may also be used by doctors when they suspect a child has suffered from head trauma or abuse at home, but who cannot remember what happened due to memory loss caused by brain swelling.
On the basis of Application, the market is segmented into Hospital Use and Clinic Use. Hospitals use biologic imaging reagents to help in diagnosis. For instance, MRI scanners are often used to diagnose tumors and other health conditions by scanning the body for unusual accumulations of fluid or tissue which may indicate cancerous growths or a tumor located on any part of the head, neck, spine, or brain. Ultrasound is also effective at detecting soft-tissue masses such as cysts and abscesses that display colors due to different types of tissues present inside them (such as fat). CT scans can be used when trauma has occurred and there may be internal bleeding not detected externally. X-ray machines are utilized since they create images based on differences in density among various substances - such as bones versus organs.
On the basis of Region, the market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The Middle East and African region had shown significant growth in the use of biologic imaging reagents over recent years as compared to other regions. This can be attributed to factors such as increased public awareness about health care facilities in these regions. Furthermore, developing economies also drive for the upsurge in demand due to their rising medical tourism industry which leads to an increase in healthcare spending by individuals. Countries such as China are now focusing on improving their hospitals with advanced equipment that will allow them to provide better treatment options.
Growth Factors For The Global Biologic Imaging Reagents Market:
The growth of the global biologic imaging reagents market, in terms of value and volume, is primarily driven by the demand for healthcare services. The use of advanced diagnostics technologies has led to an increase in patient visits during hospitalization periods. This situation leads to more patients requiring full-body examinations such as MRI or CT scanning sessions on a daily basis which creates a need for high-quality reagent products that are safe to use around humans as well as animals. Moreover, with escalating cases of diseases like cancer, it becomes necessary to diagnose them at their early stages when they can be treated easily leading to increased expenditure on diagnostic equipment and materials such as biologic imaging scanners and related accessories required for diagnostic procedures involving various types of bioimaging methods.
Up Market Research published a new report titled “Biologic Imaging Reagents Market research report which is segmented by Types (MRI Reagents, Ultrasound Reagents, X-ray and CT Reagents), By Applications (Hospital Use, Clinic Use), By Players/Companies Bayer Healthcare, Beckman Coulter, Bracco Imaging, Cardinal Health, Johnson and Johnson, Philips Healthcare, Siemens Healthcare”.
Report Scope
| Report Attributes | Report Details |
| Report Title | Biologic Imaging Reagents Market Research Report |
| By Type | MRI Reagents, Ultrasound Reagents, X-ray and CT Reagents |
| By Application | Hospital Use, Clinic Use |
| By Companies | Bayer Healthcare, Beckman Coulter, Bracco Imaging, Cardinal Health, Johnson and Johnson, Philips Healthcare, Siemens Healthcare |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 235 |
| Number of Tables & Figures | 165 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Biologic Imaging Reagents Market Report Segments:
The market is segmented by Type MRI Reagents, Ultrasound Reagents, X-ray and CT Reagents and By Application Hospital Use, Clinic Use.
Some of the companies that are profiled in this report are:
- Bayer Healthcare
- Beckman Coulter
- Bracco Imaging
- Cardinal Health
- Johnson and Johnson
- Philips Healthcare
- Siemens Healthcare
Biologic Imaging Reagents Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Biologic Imaging Reagents Market
Overview of the regional outlook of the Biologic Imaging Reagents Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Biologic Imaging Reagents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Biologic Imaging Reagents Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
- By Type:
1. MRI Reagents
2. Ultrasound Reagents
3. X-ray and CT Reagents
7. By Application:1. Hospital Use
2. Clinic Use
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Biologic Imaging Reagents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Biologic Imaging Reagents Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Biologic Imaging Reagents Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Biologic Imaging Reagents Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Biologic Imaging Reagents Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Biologic Imaging Reagents Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Biologic Imaging Reagents Market Size & Forecast, 2018-2028
4.5.1 Biologic Imaging Reagents Market Size and Y-o-Y Growth
4.5.2 Biologic Imaging Reagents Market Absolute $ Opportunity
Chapter 5 Global Biologic Imaging Reagents Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Biologic Imaging Reagents Market Size Forecast by Type
5.2.1 MRI Reagents
5.2.2 Ultrasound Reagents
5.2.3 X-ray and CT Reagents
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Biologic Imaging Reagents Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Biologic Imaging Reagents Market Size Forecast by Applications
6.2.1 Hospital Use
6.2.2 Clinic Use
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Biologic Imaging Reagents Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Biologic Imaging Reagents Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Biologic Imaging Reagents Analysis and Forecast
9.1 Introduction
9.2 North America Biologic Imaging Reagents Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Biologic Imaging Reagents Market Size Forecast by Type
9.6.1 MRI Reagents
9.6.2 Ultrasound Reagents
9.6.3 X-ray and CT Reagents
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Biologic Imaging Reagents Market Size Forecast by Applications
9.10.1 Hospital Use
9.10.2 Clinic Use
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Biologic Imaging Reagents Analysis and Forecast
10.1 Introduction
10.2 Europe Biologic Imaging Reagents Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Biologic Imaging Reagents Market Size Forecast by Type
10.6.1 MRI Reagents
10.6.2 Ultrasound Reagents
10.6.3 X-ray and CT Reagents
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Biologic Imaging Reagents Market Size Forecast by Applications
10.10.1 Hospital Use
10.10.2 Clinic Use
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Biologic Imaging Reagents Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Biologic Imaging Reagents Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Biologic Imaging Reagents Market Size Forecast by Type
11.6.1 MRI Reagents
11.6.2 Ultrasound Reagents
11.6.3 X-ray and CT Reagents
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Biologic Imaging Reagents Market Size Forecast by Applications
11.10.1 Hospital Use
11.10.2 Clinic Use
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Biologic Imaging Reagents Analysis and Forecast
12.1 Introduction
12.2 Latin America Biologic Imaging Reagents Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Biologic Imaging Reagents Market Size Forecast by Type
12.6.1 MRI Reagents
12.6.2 Ultrasound Reagents
12.6.3 X-ray and CT Reagents
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Biologic Imaging Reagents Market Size Forecast by Applications
12.10.1 Hospital Use
12.10.2 Clinic Use
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Biologic Imaging Reagents Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Biologic Imaging Reagents Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Biologic Imaging Reagents Market Size Forecast by Type
13.6.1 MRI Reagents
13.6.2 Ultrasound Reagents
13.6.3 X-ray and CT Reagents
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Biologic Imaging Reagents Market Size Forecast by Applications
13.10.1 Hospital Use
13.10.2 Clinic Use
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Biologic Imaging Reagents Market: Competitive Dashboard
14.2 Global Biologic Imaging Reagents Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer Healthcare
14.3.2 Beckman Coulter
14.3.3 Bracco Imaging
14.3.4 Cardinal Health
14.3.5 Johnson and Johnson
14.3.6 Philips Healthcare
14.3.7 Siemens Healthcare
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Biologic Imaging Reagents Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Biologic Imaging Reagents Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Biologic Imaging Reagents Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Biologic Imaging Reagents Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Biologic Imaging Reagents Market Size & Forecast, 2018-2028
4.5.1 Biologic Imaging Reagents Market Size and Y-o-Y Growth
4.5.2 Biologic Imaging Reagents Market Absolute $ Opportunity
Chapter 5 Global Biologic Imaging Reagents Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Biologic Imaging Reagents Market Size Forecast by Type
5.2.1 MRI Reagents
5.2.2 Ultrasound Reagents
5.2.3 X-ray and CT Reagents
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Biologic Imaging Reagents Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Biologic Imaging Reagents Market Size Forecast by Applications
6.2.1 Hospital Use
6.2.2 Clinic Use
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Biologic Imaging Reagents Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Biologic Imaging Reagents Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Biologic Imaging Reagents Analysis and Forecast
9.1 Introduction
9.2 North America Biologic Imaging Reagents Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Biologic Imaging Reagents Market Size Forecast by Type
9.6.1 MRI Reagents
9.6.2 Ultrasound Reagents
9.6.3 X-ray and CT Reagents
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Biologic Imaging Reagents Market Size Forecast by Applications
9.10.1 Hospital Use
9.10.2 Clinic Use
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Biologic Imaging Reagents Analysis and Forecast
10.1 Introduction
10.2 Europe Biologic Imaging Reagents Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Biologic Imaging Reagents Market Size Forecast by Type
10.6.1 MRI Reagents
10.6.2 Ultrasound Reagents
10.6.3 X-ray and CT Reagents
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Biologic Imaging Reagents Market Size Forecast by Applications
10.10.1 Hospital Use
10.10.2 Clinic Use
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Biologic Imaging Reagents Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Biologic Imaging Reagents Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Biologic Imaging Reagents Market Size Forecast by Type
11.6.1 MRI Reagents
11.6.2 Ultrasound Reagents
11.6.3 X-ray and CT Reagents
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Biologic Imaging Reagents Market Size Forecast by Applications
11.10.1 Hospital Use
11.10.2 Clinic Use
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Biologic Imaging Reagents Analysis and Forecast
12.1 Introduction
12.2 Latin America Biologic Imaging Reagents Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Biologic Imaging Reagents Market Size Forecast by Type
12.6.1 MRI Reagents
12.6.2 Ultrasound Reagents
12.6.3 X-ray and CT Reagents
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Biologic Imaging Reagents Market Size Forecast by Applications
12.10.1 Hospital Use
12.10.2 Clinic Use
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Biologic Imaging Reagents Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Biologic Imaging Reagents Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Biologic Imaging Reagents Market Size Forecast by Type
13.6.1 MRI Reagents
13.6.2 Ultrasound Reagents
13.6.3 X-ray and CT Reagents
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Biologic Imaging Reagents Market Size Forecast by Applications
13.10.1 Hospital Use
13.10.2 Clinic Use
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Biologic Imaging Reagents Market: Competitive Dashboard
14.2 Global Biologic Imaging Reagents Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer Healthcare
14.3.2 Beckman Coulter
14.3.3 Bracco Imaging
14.3.4 Cardinal Health
14.3.5 Johnson and Johnson
14.3.6 Philips Healthcare
14.3.7 Siemens Healthcare
Segments Covered in the Report
The global Biologic Imaging Reagents market has been segmented based on
By Types
The global Biologic Imaging Reagents market has been segmented based on
By Types
- MRI Reagents
- Ultrasound Reagents
- X-ray and CT Reagents
- Hospital Use
- Clinic Use
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Bayer Healthcare
- Beckman Coulter
- Bracco Imaging
- Cardinal Health
- Johnson and Johnson
- Philips Healthcare
- Siemens Healthcare
Our Clients
Related Reports
Some other reports from this category!
